nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—CYP1A1—kidney cancer	0.156	0.653	CbGaD
Nifedipine—ABCB1—kidney cancer	0.0827	0.347	CbGaD
Nifedipine—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0262	0.0537	CbGbCtD
Nifedipine—CYP3A7—Temsirolimus—kidney cancer	0.0262	0.0537	CbGbCtD
Nifedipine—ABCC3—Vincristine—kidney cancer	0.0255	0.0524	CbGbCtD
Nifedipine—CYP3A5—Temsirolimus—kidney cancer	0.0196	0.0403	CbGbCtD
Nifedipine—ABCC3—Doxorubicin—kidney cancer	0.016	0.0328	CbGbCtD
Nifedipine—ABCC2—Paclitaxel—kidney cancer	0.0135	0.0276	CbGbCtD
Nifedipine—ABCB1—Temsirolimus—kidney cancer	0.0128	0.0262	CbGbCtD
Nifedipine—CYP1A1—Erlotinib—kidney cancer	0.0123	0.0252	CbGbCtD
Nifedipine—CYP2D6—Temsirolimus—kidney cancer	0.012	0.0247	CbGbCtD
Nifedipine—ABCC2—Sorafenib—kidney cancer	0.012	0.0245	CbGbCtD
Nifedipine—ABCC2—Vinblastine—kidney cancer	0.0118	0.0242	CbGbCtD
Nifedipine—ABCC2—Vincristine—kidney cancer	0.0116	0.0238	CbGbCtD
Nifedipine—CYP3A4—Everolimus—kidney cancer	0.0113	0.0233	CbGbCtD
Nifedipine—CYP2C8—Pazopanib—kidney cancer	0.00992	0.0204	CbGbCtD
Nifedipine—ABCC2—Sunitinib—kidney cancer	0.00968	0.0199	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.00899	0.0184	CbGbCtD
Nifedipine—CYP3A7—Paclitaxel—kidney cancer	0.00899	0.0184	CbGbCtD
Nifedipine—CYP3A7—Sorafenib—kidney cancer	0.00798	0.0164	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00798	0.0164	CbGbCtD
Nifedipine—CYP3A7—Vincristine—kidney cancer	0.00775	0.0159	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00775	0.0159	CbGbCtD
Nifedipine—CYP1A2—Pazopanib—kidney cancer	0.00768	0.0158	CbGbCtD
Nifedipine—CYP3A4—Temsirolimus—kidney cancer	0.00766	0.0157	CbGbCtD
Nifedipine—CYP2B6—Sorafenib—kidney cancer	0.0076	0.0156	CbGbCtD
Nifedipine—CYP3A5—Erlotinib—kidney cancer	0.00736	0.0151	CbGbCtD
Nifedipine—ABCC2—Doxorubicin—kidney cancer	0.00725	0.0149	CbGbCtD
Nifedipine—CYP2C9—Capecitabine—kidney cancer	0.00722	0.0148	CbGbCtD
Nifedipine—CYP2C8—Erlotinib—kidney cancer	0.00708	0.0145	CbGbCtD
Nifedipine—CYP3A5—Paclitaxel—kidney cancer	0.00674	0.0138	CbGbCtD
Nifedipine—ABCB1—Pazopanib—kidney cancer	0.00672	0.0138	CbGbCtD
Nifedipine—CYP2C8—Paclitaxel—kidney cancer	0.00648	0.0133	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00647	0.0133	CbGbCtD
Nifedipine—CYP3A7—Sunitinib—kidney cancer	0.00647	0.0133	CbGbCtD
Nifedipine—CYP2D6—Pazopanib—kidney cancer	0.00633	0.013	CbGbCtD
Nifedipine—ABCB1—Dactinomycin—kidney cancer	0.00614	0.0126	CbGbCtD
Nifedipine—CYP3A5—Sorafenib—kidney cancer	0.00599	0.0123	CbGbCtD
Nifedipine—CYP3A5—Vincristine—kidney cancer	0.00581	0.0119	CbGbCtD
Nifedipine—CYP2C8—Sorafenib—kidney cancer	0.00576	0.0118	CbGbCtD
Nifedipine—CYP1A2—Erlotinib—kidney cancer	0.00548	0.0112	CbGbCtD
Nifedipine—ABCB1—Gemcitabine—kidney cancer	0.00486	0.00997	CbGbCtD
Nifedipine—CYP3A5—Sunitinib—kidney cancer	0.00485	0.00996	CbGbCtD
Nifedipine—ABCB1—Erlotinib—kidney cancer	0.00479	0.00984	CbGbCtD
Nifedipine—CYP2B6—Doxorubicin—kidney cancer	0.00461	0.00946	CbGbCtD
Nifedipine—CYP2C9—Paclitaxel—kidney cancer	0.00452	0.00928	CbGbCtD
Nifedipine—CYP2D6—Erlotinib—kidney cancer	0.00452	0.00927	CbGbCtD
Nifedipine—CYP1A2—Sorafenib—kidney cancer	0.00446	0.00915	CbGbCtD
Nifedipine—ABCB1—Paclitaxel—kidney cancer	0.00439	0.009	CbGbCtD
Nifedipine—CYP3A4—Pazopanib—kidney cancer	0.00402	0.00826	CbGbCtD
Nifedipine—CYP2C9—Sorafenib—kidney cancer	0.00402	0.00824	CbGbCtD
Nifedipine—ABCB1—Sorafenib—kidney cancer	0.0039	0.008	CbGbCtD
Nifedipine—ABCB1—Vinblastine—kidney cancer	0.00385	0.0079	CbGbCtD
Nifedipine—ABCB1—Vincristine—kidney cancer	0.00378	0.00776	CbGbCtD
Nifedipine—CYP2D6—Sorafenib—kidney cancer	0.00367	0.00754	CbGbCtD
Nifedipine—CYP2D6—Vinblastine—kidney cancer	0.00363	0.00744	CbGbCtD
Nifedipine—ABCB1—Sunitinib—kidney cancer	0.00316	0.00648	CbGbCtD
Nifedipine—CYP3A4—Erlotinib—kidney cancer	0.00287	0.00589	CbGbCtD
Nifedipine—CYP3A4—Paclitaxel—kidney cancer	0.00263	0.00539	CbGbCtD
Nifedipine—ABCB1—Doxorubicin—kidney cancer	0.00236	0.00485	CbGbCtD
Nifedipine—CYP3A4—Sorafenib—kidney cancer	0.00233	0.00479	CbGbCtD
Nifedipine—CYP3A4—Vinblastine—kidney cancer	0.00231	0.00473	CbGbCtD
Nifedipine—CYP3A4—Vincristine—kidney cancer	0.00227	0.00465	CbGbCtD
Nifedipine—CYP2D6—Doxorubicin—kidney cancer	0.00223	0.00457	CbGbCtD
Nifedipine—CYP3A4—Sunitinib—kidney cancer	0.00189	0.00388	CbGbCtD
Nifedipine—CYP3A4—Doxorubicin—kidney cancer	0.00142	0.00291	CbGbCtD
Nifedipine—CYP1A2—urine—kidney cancer	0.00141	0.0485	CbGeAlD
Nifedipine—CYP2C9—urine—kidney cancer	0.00133	0.0461	CbGeAlD
Nifedipine—CYP2E1—urine—kidney cancer	0.00127	0.0437	CbGeAlD
Nifedipine—CYP3A4—urine—kidney cancer	0.00102	0.0351	CbGeAlD
Nifedipine—CYP2D6—urine—kidney cancer	0.001	0.0346	CbGeAlD
Nifedipine—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000882	0.0304	CbGeAlD
Nifedipine—CACNA1H—gonad—kidney cancer	0.000794	0.0274	CbGeAlD
Nifedipine—CACNB2—cortex of kidney—kidney cancer	0.000787	0.0272	CbGeAlD
Nifedipine—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000755	0.0261	CbGeAlD
Nifedipine—CACNB2—cardiac atrium—kidney cancer	0.000749	0.0258	CbGeAlD
Nifedipine—CACNA1D—cardiac atrium—kidney cancer	0.000654	0.0226	CbGeAlD
Nifedipine—CALM3—nephron tubule—kidney cancer	0.000622	0.0215	CbGeAlD
Nifedipine—ABCC3—renal system—kidney cancer	0.000614	0.0212	CbGeAlD
Nifedipine—CACNA1C—cardiac atrium—kidney cancer	0.000604	0.0209	CbGeAlD
Nifedipine—ABCC3—kidney—kidney cancer	0.000593	0.0205	CbGeAlD
Nifedipine—ABCC2—nephron tubule—kidney cancer	0.000539	0.0186	CbGeAlD
Nifedipine—CALM3—cortex of kidney—kidney cancer	0.000532	0.0184	CbGeAlD
Nifedipine—CALM3—cardiac atrium—kidney cancer	0.000506	0.0175	CbGeAlD
Nifedipine—ABCC2—renal system—kidney cancer	0.00049	0.0169	CbGeAlD
Nifedipine—CALM2—nephron tubule—kidney cancer	0.000488	0.0168	CbGeAlD
Nifedipine—CALM1—nephron tubule—kidney cancer	0.000486	0.0168	CbGeAlD
Nifedipine—ABCC2—kidney—kidney cancer	0.000474	0.0164	CbGeAlD
Nifedipine—ABCC2—cortex of kidney—kidney cancer	0.000462	0.0159	CbGeAlD
Nifedipine—CALM2—renal system—kidney cancer	0.000444	0.0153	CbGeAlD
Nifedipine—CALM1—renal system—kidney cancer	0.000442	0.0152	CbGeAlD
Nifedipine—CALM2—kidney—kidney cancer	0.000429	0.0148	CbGeAlD
Nifedipine—CALM1—kidney—kidney cancer	0.000427	0.0147	CbGeAlD
Nifedipine—CALM2—cortex of kidney—kidney cancer	0.000418	0.0144	CbGeAlD
Nifedipine—CALM1—cortex of kidney—kidney cancer	0.000416	0.0144	CbGeAlD
Nifedipine—CALM2—gonad—kidney cancer	0.000398	0.0137	CbGeAlD
Nifedipine—CALM2—cardiac atrium—kidney cancer	0.000397	0.0137	CbGeAlD
Nifedipine—CALM1—gonad—kidney cancer	0.000396	0.0137	CbGeAlD
Nifedipine—CALM1—cardiac atrium—kidney cancer	0.000396	0.0137	CbGeAlD
Nifedipine—Clevidipine—BCHE—kidney cancer	0.00037	0.318	CrCbGaD
Nifedipine—CYP2C8—renal system—kidney cancer	0.000368	0.0127	CbGeAlD
Nifedipine—CYP3A5—nephron tubule—kidney cancer	0.000365	0.0126	CbGeAlD
Nifedipine—CYP2B6—nephron tubule—kidney cancer	0.000363	0.0125	CbGeAlD
Nifedipine—CYP2C8—kidney—kidney cancer	0.000355	0.0123	CbGeAlD
Nifedipine—CYP1A2—renal system—kidney cancer	0.000344	0.0119	CbGeAlD
Nifedipine—CYP2E1—nephron tubule—kidney cancer	0.000341	0.0118	CbGeAlD
Nifedipine—CYP1A1—renal system—kidney cancer	0.000339	0.0117	CbGeAlD
Nifedipine—CYP3A5—renal system—kidney cancer	0.000332	0.0115	CbGeAlD
Nifedipine—CYP2B6—renal system—kidney cancer	0.00033	0.0114	CbGeAlD
Nifedipine—CYP1A1—kidney—kidney cancer	0.000328	0.0113	CbGeAlD
Nifedipine—CYP3A5—kidney—kidney cancer	0.000321	0.0111	CbGeAlD
Nifedipine—CYP2B6—kidney—kidney cancer	0.000319	0.011	CbGeAlD
Nifedipine—CYP3A5—cortex of kidney—kidney cancer	0.000312	0.0108	CbGeAlD
Nifedipine—CYP2E1—renal system—kidney cancer	0.00031	0.0107	CbGeAlD
Nifedipine—CYP1A1—cardiac atrium—kidney cancer	0.000304	0.0105	CbGeAlD
Nifedipine—CYP2E1—kidney—kidney cancer	0.000299	0.0103	CbGeAlD
Nifedipine—CYP2B6—gonad—kidney cancer	0.000296	0.0102	CbGeAlD
Nifedipine—CYP2E1—cortex of kidney—kidney cancer	0.000291	0.0101	CbGeAlD
Nifedipine—CYP3A4—renal system—kidney cancer	0.000249	0.0086	CbGeAlD
Nifedipine—CYP2D6—renal system—kidney cancer	0.000245	0.00846	CbGeAlD
Nifedipine—CYP3A4—kidney—kidney cancer	0.000241	0.00831	CbGeAlD
Nifedipine—CYP2D6—kidney—kidney cancer	0.000237	0.00818	CbGeAlD
Nifedipine—Amlodipine—CYP1A1—kidney cancer	0.000211	0.181	CrCbGaD
Nifedipine—ABCB1—nephron tubule—kidney cancer	0.000194	0.00669	CbGeAlD
Nifedipine—ABCB1—renal system—kidney cancer	0.000176	0.00609	CbGeAlD
Nifedipine—ABCB1—kidney—kidney cancer	0.00017	0.00588	CbGeAlD
Nifedipine—ABCB1—cortex of kidney—kidney cancer	0.000166	0.00573	CbGeAlD
Nifedipine—ABCB1—gonad—kidney cancer	0.000158	0.00546	CbGeAlD
Nifedipine—Nisoldipine—ABCB1—kidney cancer	0.000139	0.119	CrCbGaD
Nifedipine—Nitrendipine—ABCB1—kidney cancer	0.00013	0.112	CrCbGaD
Nifedipine—Amlodipine—ABCB1—kidney cancer	0.000112	0.0962	CrCbGaD
Nifedipine—Felodipine—ABCB1—kidney cancer	0.000104	0.0889	CrCbGaD
Nifedipine—Nicardipine—ABCB1—kidney cancer	9.86e-05	0.0847	CrCbGaD
Nifedipine—Mood swings—Doxorubicin—kidney cancer	6.02e-05	0.000397	CcSEcCtD
Nifedipine—Diarrhoea—Sunitinib—kidney cancer	6.02e-05	0.000397	CcSEcCtD
Nifedipine—Ataxia—Doxorubicin—kidney cancer	5.98e-05	0.000394	CcSEcCtD
Nifedipine—Mental disorder—Capecitabine—kidney cancer	5.98e-05	0.000394	CcSEcCtD
Nifedipine—Asthenia—Dactinomycin—kidney cancer	5.97e-05	0.000394	CcSEcCtD
Nifedipine—Confusional state—Paclitaxel—kidney cancer	5.96e-05	0.000393	CcSEcCtD
Nifedipine—Malnutrition—Capecitabine—kidney cancer	5.94e-05	0.000392	CcSEcCtD
Nifedipine—Erythema—Capecitabine—kidney cancer	5.94e-05	0.000392	CcSEcCtD
Nifedipine—Anaphylactic shock—Paclitaxel—kidney cancer	5.91e-05	0.00039	CcSEcCtD
Nifedipine—Oedema—Paclitaxel—kidney cancer	5.91e-05	0.00039	CcSEcCtD
Nifedipine—Abdominal pain—Vincristine—kidney cancer	5.88e-05	0.000388	CcSEcCtD
Nifedipine—Body temperature increased—Vincristine—kidney cancer	5.88e-05	0.000388	CcSEcCtD
Nifedipine—Liver function test abnormal—Doxorubicin—kidney cancer	5.87e-05	0.000387	CcSEcCtD
Nifedipine—Flatulence—Capecitabine—kidney cancer	5.85e-05	0.000386	CcSEcCtD
Nifedipine—Dysgeusia—Capecitabine—kidney cancer	5.82e-05	0.000384	CcSEcCtD
Nifedipine—Dizziness—Sunitinib—kidney cancer	5.81e-05	0.000384	CcSEcCtD
Nifedipine—Feeling abnormal—Gemcitabine—kidney cancer	5.81e-05	0.000384	CcSEcCtD
Nifedipine—Shock—Paclitaxel—kidney cancer	5.81e-05	0.000383	CcSEcCtD
Nifedipine—Vomiting—Sorafenib—kidney cancer	5.81e-05	0.000383	CcSEcCtD
Nifedipine—Orthostatic hypotension—Doxorubicin—kidney cancer	5.81e-05	0.000383	CcSEcCtD
Nifedipine—Nervous system disorder—Paclitaxel—kidney cancer	5.79e-05	0.000382	CcSEcCtD
Nifedipine—Thrombocytopenia—Paclitaxel—kidney cancer	5.78e-05	0.000382	CcSEcCtD
Nifedipine—Tachycardia—Paclitaxel—kidney cancer	5.77e-05	0.00038	CcSEcCtD
Nifedipine—Rash—Sorafenib—kidney cancer	5.76e-05	0.00038	CcSEcCtD
Nifedipine—Dermatitis—Sorafenib—kidney cancer	5.76e-05	0.00038	CcSEcCtD
Nifedipine—Back pain—Capecitabine—kidney cancer	5.75e-05	0.000379	CcSEcCtD
Nifedipine—Breast disorder—Doxorubicin—kidney cancer	5.75e-05	0.000379	CcSEcCtD
Nifedipine—Skin disorder—Paclitaxel—kidney cancer	5.74e-05	0.000378	CcSEcCtD
Nifedipine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	5.73e-05	0.000378	CcSEcCtD
Nifedipine—Headache—Sorafenib—kidney cancer	5.72e-05	0.000378	CcSEcCtD
Nifedipine—Muscle spasms—Capecitabine—kidney cancer	5.71e-05	0.000377	CcSEcCtD
Nifedipine—Hyperhidrosis—Paclitaxel—kidney cancer	5.71e-05	0.000377	CcSEcCtD
Nifedipine—Diarrhoea—Dactinomycin—kidney cancer	5.7e-05	0.000376	CcSEcCtD
Nifedipine—Anorexia—Paclitaxel—kidney cancer	5.63e-05	0.000371	CcSEcCtD
Nifedipine—Muscular weakness—Doxorubicin—kidney cancer	5.61e-05	0.00037	CcSEcCtD
Nifedipine—Alanine aminotransferase increased—Doxorubicin—kidney cancer	5.61e-05	0.00037	CcSEcCtD
Nifedipine—Vision blurred—Capecitabine—kidney cancer	5.6e-05	0.000369	CcSEcCtD
Nifedipine—Vomiting—Sunitinib—kidney cancer	5.59e-05	0.000369	CcSEcCtD
Nifedipine—Body temperature increased—Gemcitabine—kidney cancer	5.58e-05	0.000368	CcSEcCtD
Nifedipine—Tremor—Capecitabine—kidney cancer	5.57e-05	0.000367	CcSEcCtD
Nifedipine—Rash—Sunitinib—kidney cancer	5.54e-05	0.000366	CcSEcCtD
Nifedipine—Dermatitis—Sunitinib—kidney cancer	5.54e-05	0.000365	CcSEcCtD
Nifedipine—Abdominal distension—Doxorubicin—kidney cancer	5.53e-05	0.000365	CcSEcCtD
Nifedipine—Hypotension—Paclitaxel—kidney cancer	5.52e-05	0.000364	CcSEcCtD
Nifedipine—Ill-defined disorder—Capecitabine—kidney cancer	5.51e-05	0.000364	CcSEcCtD
Nifedipine—Headache—Sunitinib—kidney cancer	5.51e-05	0.000363	CcSEcCtD
Nifedipine—Dysphagia—Doxorubicin—kidney cancer	5.5e-05	0.000362	CcSEcCtD
Nifedipine—Anaemia—Capecitabine—kidney cancer	5.49e-05	0.000362	CcSEcCtD
Nifedipine—Hypersensitivity—Vincristine—kidney cancer	5.48e-05	0.000361	CcSEcCtD
Nifedipine—Eosinophilia—Doxorubicin—kidney cancer	5.44e-05	0.000359	CcSEcCtD
Nifedipine—Nausea—Sorafenib—kidney cancer	5.43e-05	0.000358	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	5.38e-05	0.000355	CcSEcCtD
Nifedipine—Malaise—Capecitabine—kidney cancer	5.36e-05	0.000353	CcSEcCtD
Nifedipine—Angina pectoris—Doxorubicin—kidney cancer	5.35e-05	0.000353	CcSEcCtD
Nifedipine—Insomnia—Paclitaxel—kidney cancer	5.34e-05	0.000352	CcSEcCtD
Nifedipine—Vertigo—Capecitabine—kidney cancer	5.34e-05	0.000352	CcSEcCtD
Nifedipine—Asthenia—Vincristine—kidney cancer	5.34e-05	0.000352	CcSEcCtD
Nifedipine—Syncope—Capecitabine—kidney cancer	5.33e-05	0.000351	CcSEcCtD
Nifedipine—Leukopenia—Capecitabine—kidney cancer	5.32e-05	0.000351	CcSEcCtD
Nifedipine—Paraesthesia—Paclitaxel—kidney cancer	5.3e-05	0.00035	CcSEcCtD
Nifedipine—Vomiting—Dactinomycin—kidney cancer	5.29e-05	0.000349	CcSEcCtD
Nifedipine—Dyspnoea—Paclitaxel—kidney cancer	5.27e-05	0.000347	CcSEcCtD
Nifedipine—Somnolence—Paclitaxel—kidney cancer	5.25e-05	0.000346	CcSEcCtD
Nifedipine—Palpitations—Capecitabine—kidney cancer	5.25e-05	0.000346	CcSEcCtD
Nifedipine—Rash—Dactinomycin—kidney cancer	5.25e-05	0.000346	CcSEcCtD
Nifedipine—Nausea—Sunitinib—kidney cancer	5.22e-05	0.000345	CcSEcCtD
Nifedipine—Loss of consciousness—Capecitabine—kidney cancer	5.22e-05	0.000344	CcSEcCtD
Nifedipine—Dyspepsia—Paclitaxel—kidney cancer	5.2e-05	0.000343	CcSEcCtD
Nifedipine—Cough—Capecitabine—kidney cancer	5.18e-05	0.000342	CcSEcCtD
Nifedipine—Dysuria—Doxorubicin—kidney cancer	5.14e-05	0.000339	CcSEcCtD
Nifedipine—Decreased appetite—Paclitaxel—kidney cancer	5.14e-05	0.000339	CcSEcCtD
Nifedipine—Upper respiratory tract infection—Doxorubicin—kidney cancer	5.11e-05	0.000337	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Paclitaxel—kidney cancer	5.1e-05	0.000336	CcSEcCtD
Nifedipine—Fatigue—Paclitaxel—kidney cancer	5.09e-05	0.000336	CcSEcCtD
Nifedipine—Diarrhoea—Vincristine—kidney cancer	5.09e-05	0.000336	CcSEcCtD
Nifedipine—Pollakiuria—Doxorubicin—kidney cancer	5.08e-05	0.000335	CcSEcCtD
Nifedipine—Asthenia—Gemcitabine—kidney cancer	5.06e-05	0.000334	CcSEcCtD
Nifedipine—Chest pain—Capecitabine—kidney cancer	5.06e-05	0.000334	CcSEcCtD
Nifedipine—Arthralgia—Capecitabine—kidney cancer	5.06e-05	0.000334	CcSEcCtD
Nifedipine—Myalgia—Capecitabine—kidney cancer	5.06e-05	0.000334	CcSEcCtD
Nifedipine—Constipation—Paclitaxel—kidney cancer	5.05e-05	0.000333	CcSEcCtD
Nifedipine—Pain—Paclitaxel—kidney cancer	5.05e-05	0.000333	CcSEcCtD
Nifedipine—Anxiety—Capecitabine—kidney cancer	5.04e-05	0.000332	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	5.02e-05	0.000331	CcSEcCtD
Nifedipine—Photosensitivity reaction—Doxorubicin—kidney cancer	5.02e-05	0.000331	CcSEcCtD
Nifedipine—Weight increased—Doxorubicin—kidney cancer	5e-05	0.00033	CcSEcCtD
Nifedipine—Discomfort—Capecitabine—kidney cancer	5e-05	0.00033	CcSEcCtD
Nifedipine—Pruritus—Gemcitabine—kidney cancer	4.99e-05	0.000329	CcSEcCtD
Nifedipine—Weight decreased—Doxorubicin—kidney cancer	4.97e-05	0.000328	CcSEcCtD
Nifedipine—Hyperglycaemia—Doxorubicin—kidney cancer	4.96e-05	0.000327	CcSEcCtD
Nifedipine—Dry mouth—Capecitabine—kidney cancer	4.95e-05	0.000326	CcSEcCtD
Nifedipine—Nausea—Dactinomycin—kidney cancer	4.94e-05	0.000326	CcSEcCtD
Nifedipine—Dizziness—Vincristine—kidney cancer	4.92e-05	0.000324	CcSEcCtD
Nifedipine—Confusional state—Capecitabine—kidney cancer	4.89e-05	0.000322	CcSEcCtD
Nifedipine—Feeling abnormal—Paclitaxel—kidney cancer	4.87e-05	0.000321	CcSEcCtD
Nifedipine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	4.86e-05	0.00032	CcSEcCtD
Nifedipine—Oedema—Capecitabine—kidney cancer	4.85e-05	0.00032	CcSEcCtD
Nifedipine—Gastrointestinal pain—Paclitaxel—kidney cancer	4.83e-05	0.000319	CcSEcCtD
Nifedipine—Diarrhoea—Gemcitabine—kidney cancer	4.83e-05	0.000318	CcSEcCtD
Nifedipine—Jaundice—Doxorubicin—kidney cancer	4.78e-05	0.000315	CcSEcCtD
Nifedipine—Shock—Capecitabine—kidney cancer	4.77e-05	0.000315	CcSEcCtD
Nifedipine—Conjunctivitis—Doxorubicin—kidney cancer	4.76e-05	0.000314	CcSEcCtD
Nifedipine—Nervous system disorder—Capecitabine—kidney cancer	4.75e-05	0.000314	CcSEcCtD
Nifedipine—Thrombocytopenia—Capecitabine—kidney cancer	4.75e-05	0.000313	CcSEcCtD
Nifedipine—Tachycardia—Capecitabine—kidney cancer	4.73e-05	0.000312	CcSEcCtD
Nifedipine—Vomiting—Vincristine—kidney cancer	4.73e-05	0.000312	CcSEcCtD
Nifedipine—Skin disorder—Capecitabine—kidney cancer	4.71e-05	0.000311	CcSEcCtD
Nifedipine—Sweating—Doxorubicin—kidney cancer	4.7e-05	0.00031	CcSEcCtD
Nifedipine—Urticaria—Paclitaxel—kidney cancer	4.69e-05	0.00031	CcSEcCtD
Nifedipine—Rash—Vincristine—kidney cancer	4.69e-05	0.000309	CcSEcCtD
Nifedipine—Hyperhidrosis—Capecitabine—kidney cancer	4.69e-05	0.000309	CcSEcCtD
Nifedipine—Dermatitis—Vincristine—kidney cancer	4.69e-05	0.000309	CcSEcCtD
Nifedipine—Haematuria—Doxorubicin—kidney cancer	4.67e-05	0.000308	CcSEcCtD
Nifedipine—Abdominal pain—Paclitaxel—kidney cancer	4.67e-05	0.000308	CcSEcCtD
Nifedipine—Body temperature increased—Paclitaxel—kidney cancer	4.67e-05	0.000308	CcSEcCtD
Nifedipine—Headache—Vincristine—kidney cancer	4.66e-05	0.000307	CcSEcCtD
Nifedipine—Hepatobiliary disease—Doxorubicin—kidney cancer	4.63e-05	0.000306	CcSEcCtD
Nifedipine—Epistaxis—Doxorubicin—kidney cancer	4.62e-05	0.000305	CcSEcCtD
Nifedipine—Anorexia—Capecitabine—kidney cancer	4.62e-05	0.000305	CcSEcCtD
Nifedipine—Sinusitis—Doxorubicin—kidney cancer	4.6e-05	0.000303	CcSEcCtD
Nifedipine—Agranulocytosis—Doxorubicin—kidney cancer	4.57e-05	0.000302	CcSEcCtD
Nifedipine—Hypotension—Capecitabine—kidney cancer	4.53e-05	0.000299	CcSEcCtD
Nifedipine—Vomiting—Gemcitabine—kidney cancer	4.49e-05	0.000296	CcSEcCtD
Nifedipine—Bradycardia—Doxorubicin—kidney cancer	4.48e-05	0.000295	CcSEcCtD
Nifedipine—Rash—Gemcitabine—kidney cancer	4.45e-05	0.000293	CcSEcCtD
Nifedipine—Dermatitis—Gemcitabine—kidney cancer	4.44e-05	0.000293	CcSEcCtD
Nifedipine—Haemoglobin—Doxorubicin—kidney cancer	4.42e-05	0.000292	CcSEcCtD
Nifedipine—Headache—Gemcitabine—kidney cancer	4.42e-05	0.000292	CcSEcCtD
Nifedipine—Nausea—Vincristine—kidney cancer	4.42e-05	0.000291	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Capecitabine—kidney cancer	4.42e-05	0.000291	CcSEcCtD
Nifedipine—Rhinitis—Doxorubicin—kidney cancer	4.41e-05	0.000291	CcSEcCtD
Nifedipine—Haemorrhage—Doxorubicin—kidney cancer	4.4e-05	0.00029	CcSEcCtD
Nifedipine—Hepatitis—Doxorubicin—kidney cancer	4.4e-05	0.00029	CcSEcCtD
Nifedipine—Insomnia—Capecitabine—kidney cancer	4.38e-05	0.000289	CcSEcCtD
Nifedipine—Hypoaesthesia—Doxorubicin—kidney cancer	4.38e-05	0.000289	CcSEcCtD
Nifedipine—Pharyngitis—Doxorubicin—kidney cancer	4.37e-05	0.000288	CcSEcCtD
Nifedipine—Paraesthesia—Capecitabine—kidney cancer	4.35e-05	0.000287	CcSEcCtD
Nifedipine—Hypersensitivity—Paclitaxel—kidney cancer	4.35e-05	0.000287	CcSEcCtD
Nifedipine—Urinary tract disorder—Doxorubicin—kidney cancer	4.34e-05	0.000287	CcSEcCtD
Nifedipine—Oedema peripheral—Doxorubicin—kidney cancer	4.33e-05	0.000286	CcSEcCtD
Nifedipine—Connective tissue disorder—Doxorubicin—kidney cancer	4.32e-05	0.000285	CcSEcCtD
Nifedipine—Dyspnoea—Capecitabine—kidney cancer	4.32e-05	0.000285	CcSEcCtD
Nifedipine—Urethral disorder—Doxorubicin—kidney cancer	4.31e-05	0.000284	CcSEcCtD
Nifedipine—Dyspepsia—Capecitabine—kidney cancer	4.27e-05	0.000281	CcSEcCtD
Nifedipine—Visual impairment—Doxorubicin—kidney cancer	4.24e-05	0.00028	CcSEcCtD
Nifedipine—Asthenia—Paclitaxel—kidney cancer	4.24e-05	0.00028	CcSEcCtD
Nifedipine—Decreased appetite—Capecitabine—kidney cancer	4.21e-05	0.000278	CcSEcCtD
Nifedipine—Nausea—Gemcitabine—kidney cancer	4.19e-05	0.000276	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Capecitabine—kidney cancer	4.19e-05	0.000276	CcSEcCtD
Nifedipine—Fatigue—Capecitabine—kidney cancer	4.18e-05	0.000276	CcSEcCtD
Nifedipine—Pruritus—Paclitaxel—kidney cancer	4.18e-05	0.000276	CcSEcCtD
Nifedipine—Erythema multiforme—Doxorubicin—kidney cancer	4.16e-05	0.000274	CcSEcCtD
Nifedipine—Pain—Capecitabine—kidney cancer	4.15e-05	0.000273	CcSEcCtD
Nifedipine—Constipation—Capecitabine—kidney cancer	4.15e-05	0.000273	CcSEcCtD
Nifedipine—Eye disorder—Doxorubicin—kidney cancer	4.11e-05	0.000271	CcSEcCtD
Nifedipine—Tinnitus—Doxorubicin—kidney cancer	4.1e-05	0.000271	CcSEcCtD
Nifedipine—Flushing—Doxorubicin—kidney cancer	4.08e-05	0.000269	CcSEcCtD
Nifedipine—Cardiac disorder—Doxorubicin—kidney cancer	4.08e-05	0.000269	CcSEcCtD
Nifedipine—Diarrhoea—Paclitaxel—kidney cancer	4.04e-05	0.000267	CcSEcCtD
Nifedipine—Feeling abnormal—Capecitabine—kidney cancer	3.99e-05	0.000264	CcSEcCtD
Nifedipine—Angiopathy—Doxorubicin—kidney cancer	3.99e-05	0.000263	CcSEcCtD
Nifedipine—Immune system disorder—Doxorubicin—kidney cancer	3.97e-05	0.000262	CcSEcCtD
Nifedipine—Gastrointestinal pain—Capecitabine—kidney cancer	3.96e-05	0.000261	CcSEcCtD
Nifedipine—Mediastinal disorder—Doxorubicin—kidney cancer	3.96e-05	0.000261	CcSEcCtD
Nifedipine—Chills—Doxorubicin—kidney cancer	3.95e-05	0.00026	CcSEcCtD
Nifedipine—Arrhythmia—Doxorubicin—kidney cancer	3.93e-05	0.000259	CcSEcCtD
Nifedipine—Dizziness—Paclitaxel—kidney cancer	3.91e-05	0.000258	CcSEcCtD
Nifedipine—Alopecia—Doxorubicin—kidney cancer	3.89e-05	0.000256	CcSEcCtD
Nifedipine—Mental disorder—Doxorubicin—kidney cancer	3.85e-05	0.000254	CcSEcCtD
Nifedipine—Urticaria—Capecitabine—kidney cancer	3.85e-05	0.000254	CcSEcCtD
Nifedipine—Abdominal pain—Capecitabine—kidney cancer	3.83e-05	0.000253	CcSEcCtD
Nifedipine—Body temperature increased—Capecitabine—kidney cancer	3.83e-05	0.000253	CcSEcCtD
Nifedipine—Erythema—Doxorubicin—kidney cancer	3.83e-05	0.000253	CcSEcCtD
Nifedipine—Malnutrition—Doxorubicin—kidney cancer	3.83e-05	0.000253	CcSEcCtD
Nifedipine—Flatulence—Doxorubicin—kidney cancer	3.77e-05	0.000249	CcSEcCtD
Nifedipine—Tension—Doxorubicin—kidney cancer	3.76e-05	0.000248	CcSEcCtD
Nifedipine—Vomiting—Paclitaxel—kidney cancer	3.76e-05	0.000248	CcSEcCtD
Nifedipine—Dysgeusia—Doxorubicin—kidney cancer	3.75e-05	0.000247	CcSEcCtD
Nifedipine—Rash—Paclitaxel—kidney cancer	3.72e-05	0.000246	CcSEcCtD
Nifedipine—Dermatitis—Paclitaxel—kidney cancer	3.72e-05	0.000245	CcSEcCtD
Nifedipine—Nervousness—Doxorubicin—kidney cancer	3.72e-05	0.000245	CcSEcCtD
Nifedipine—Back pain—Doxorubicin—kidney cancer	3.7e-05	0.000244	CcSEcCtD
Nifedipine—Headache—Paclitaxel—kidney cancer	3.7e-05	0.000244	CcSEcCtD
Nifedipine—Muscle spasms—Doxorubicin—kidney cancer	3.68e-05	0.000243	CcSEcCtD
Nifedipine—Vision blurred—Doxorubicin—kidney cancer	3.61e-05	0.000238	CcSEcCtD
Nifedipine—Hypersensitivity—Capecitabine—kidney cancer	3.57e-05	0.000236	CcSEcCtD
Nifedipine—Ill-defined disorder—Doxorubicin—kidney cancer	3.55e-05	0.000234	CcSEcCtD
Nifedipine—Anaemia—Doxorubicin—kidney cancer	3.54e-05	0.000233	CcSEcCtD
Nifedipine—Agitation—Doxorubicin—kidney cancer	3.52e-05	0.000232	CcSEcCtD
Nifedipine—Nausea—Paclitaxel—kidney cancer	3.51e-05	0.000231	CcSEcCtD
Nifedipine—Asthenia—Capecitabine—kidney cancer	3.48e-05	0.000229	CcSEcCtD
Nifedipine—Malaise—Doxorubicin—kidney cancer	3.45e-05	0.000228	CcSEcCtD
Nifedipine—Vertigo—Doxorubicin—kidney cancer	3.44e-05	0.000227	CcSEcCtD
Nifedipine—Syncope—Doxorubicin—kidney cancer	3.43e-05	0.000226	CcSEcCtD
Nifedipine—Pruritus—Capecitabine—kidney cancer	3.43e-05	0.000226	CcSEcCtD
Nifedipine—Leukopenia—Doxorubicin—kidney cancer	3.43e-05	0.000226	CcSEcCtD
Nifedipine—Palpitations—Doxorubicin—kidney cancer	3.38e-05	0.000223	CcSEcCtD
Nifedipine—Loss of consciousness—Doxorubicin—kidney cancer	3.37e-05	0.000222	CcSEcCtD
Nifedipine—Cough—Doxorubicin—kidney cancer	3.34e-05	0.00022	CcSEcCtD
Nifedipine—Diarrhoea—Capecitabine—kidney cancer	3.32e-05	0.000219	CcSEcCtD
Nifedipine—Arthralgia—Doxorubicin—kidney cancer	3.26e-05	0.000215	CcSEcCtD
Nifedipine—Chest pain—Doxorubicin—kidney cancer	3.26e-05	0.000215	CcSEcCtD
Nifedipine—Myalgia—Doxorubicin—kidney cancer	3.26e-05	0.000215	CcSEcCtD
Nifedipine—Anxiety—Doxorubicin—kidney cancer	3.25e-05	0.000214	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.24e-05	0.000214	CcSEcCtD
Nifedipine—Discomfort—Doxorubicin—kidney cancer	3.22e-05	0.000212	CcSEcCtD
Nifedipine—Dizziness—Capecitabine—kidney cancer	3.21e-05	0.000211	CcSEcCtD
Nifedipine—Dry mouth—Doxorubicin—kidney cancer	3.19e-05	0.00021	CcSEcCtD
Nifedipine—Confusional state—Doxorubicin—kidney cancer	3.15e-05	0.000208	CcSEcCtD
Nifedipine—Oedema—Doxorubicin—kidney cancer	3.12e-05	0.000206	CcSEcCtD
Nifedipine—Anaphylactic shock—Doxorubicin—kidney cancer	3.12e-05	0.000206	CcSEcCtD
Nifedipine—Vomiting—Capecitabine—kidney cancer	3.08e-05	0.000203	CcSEcCtD
Nifedipine—Shock—Doxorubicin—kidney cancer	3.07e-05	0.000203	CcSEcCtD
Nifedipine—Nervous system disorder—Doxorubicin—kidney cancer	3.06e-05	0.000202	CcSEcCtD
Nifedipine—Thrombocytopenia—Doxorubicin—kidney cancer	3.06e-05	0.000202	CcSEcCtD
Nifedipine—Rash—Capecitabine—kidney cancer	3.06e-05	0.000202	CcSEcCtD
Nifedipine—Dermatitis—Capecitabine—kidney cancer	3.05e-05	0.000201	CcSEcCtD
Nifedipine—Tachycardia—Doxorubicin—kidney cancer	3.05e-05	0.000201	CcSEcCtD
Nifedipine—Headache—Capecitabine—kidney cancer	3.04e-05	0.0002	CcSEcCtD
Nifedipine—Skin disorder—Doxorubicin—kidney cancer	3.04e-05	0.0002	CcSEcCtD
Nifedipine—Hyperhidrosis—Doxorubicin—kidney cancer	3.02e-05	0.000199	CcSEcCtD
Nifedipine—Anorexia—Doxorubicin—kidney cancer	2.98e-05	0.000196	CcSEcCtD
Nifedipine—Hypotension—Doxorubicin—kidney cancer	2.92e-05	0.000193	CcSEcCtD
Nifedipine—Nausea—Capecitabine—kidney cancer	2.88e-05	0.00019	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.85e-05	0.000188	CcSEcCtD
Nifedipine—Insomnia—Doxorubicin—kidney cancer	2.83e-05	0.000186	CcSEcCtD
Nifedipine—Paraesthesia—Doxorubicin—kidney cancer	2.81e-05	0.000185	CcSEcCtD
Nifedipine—Dyspnoea—Doxorubicin—kidney cancer	2.79e-05	0.000184	CcSEcCtD
Nifedipine—Somnolence—Doxorubicin—kidney cancer	2.78e-05	0.000183	CcSEcCtD
Nifedipine—Dyspepsia—Doxorubicin—kidney cancer	2.75e-05	0.000181	CcSEcCtD
Nifedipine—Decreased appetite—Doxorubicin—kidney cancer	2.72e-05	0.000179	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.7e-05	0.000178	CcSEcCtD
Nifedipine—Fatigue—Doxorubicin—kidney cancer	2.69e-05	0.000178	CcSEcCtD
Nifedipine—Constipation—Doxorubicin—kidney cancer	2.67e-05	0.000176	CcSEcCtD
Nifedipine—Pain—Doxorubicin—kidney cancer	2.67e-05	0.000176	CcSEcCtD
Nifedipine—Feeling abnormal—Doxorubicin—kidney cancer	2.58e-05	0.00017	CcSEcCtD
Nifedipine—Gastrointestinal pain—Doxorubicin—kidney cancer	2.56e-05	0.000169	CcSEcCtD
Nifedipine—Urticaria—Doxorubicin—kidney cancer	2.48e-05	0.000164	CcSEcCtD
Nifedipine—Abdominal pain—Doxorubicin—kidney cancer	2.47e-05	0.000163	CcSEcCtD
Nifedipine—Body temperature increased—Doxorubicin—kidney cancer	2.47e-05	0.000163	CcSEcCtD
Nifedipine—Hypersensitivity—Doxorubicin—kidney cancer	2.3e-05	0.000152	CcSEcCtD
Nifedipine—Asthenia—Doxorubicin—kidney cancer	2.24e-05	0.000148	CcSEcCtD
Nifedipine—Pruritus—Doxorubicin—kidney cancer	2.21e-05	0.000146	CcSEcCtD
Nifedipine—Diarrhoea—Doxorubicin—kidney cancer	2.14e-05	0.000141	CcSEcCtD
Nifedipine—Dizziness—Doxorubicin—kidney cancer	2.07e-05	0.000136	CcSEcCtD
Nifedipine—Vomiting—Doxorubicin—kidney cancer	1.99e-05	0.000131	CcSEcCtD
Nifedipine—Rash—Doxorubicin—kidney cancer	1.97e-05	0.00013	CcSEcCtD
Nifedipine—Dermatitis—Doxorubicin—kidney cancer	1.97e-05	0.00013	CcSEcCtD
Nifedipine—Headache—Doxorubicin—kidney cancer	1.96e-05	0.000129	CcSEcCtD
Nifedipine—Nausea—Doxorubicin—kidney cancer	1.86e-05	0.000122	CcSEcCtD
Nifedipine—CYP2D6—Metabolism—ABCB1—kidney cancer	2.53e-06	2.73e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CD4—kidney cancer	2.52e-06	2.72e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ACHE—kidney cancer	2.52e-06	2.72e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTT1—kidney cancer	2.52e-06	2.72e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—ABCB1—kidney cancer	2.51e-06	2.7e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—RAF1—kidney cancer	2.51e-06	2.7e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—RAF1—kidney cancer	2.51e-06	2.7e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—POMC—kidney cancer	2.5e-06	2.69e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—RELA—kidney cancer	2.49e-06	2.69e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—RELA—kidney cancer	2.49e-06	2.69e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—ERBB2—kidney cancer	2.48e-06	2.67e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—ERBB2—kidney cancer	2.48e-06	2.67e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—CYP1A1—kidney cancer	2.47e-06	2.66e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PTGS2—kidney cancer	2.47e-06	2.66e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—IL2—kidney cancer	2.46e-06	2.65e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—IL2—kidney cancer	2.46e-06	2.65e-05	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—PIK3CA—kidney cancer	2.46e-06	2.65e-05	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—PIK3CA—kidney cancer	2.46e-06	2.65e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—GSTM1—kidney cancer	2.45e-06	2.65e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MTOR—kidney cancer	2.45e-06	2.64e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MTOR—kidney cancer	2.45e-06	2.64e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—POMC—kidney cancer	2.44e-06	2.64e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CD4—kidney cancer	2.44e-06	2.63e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CD4—kidney cancer	2.44e-06	2.63e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—POMC—kidney cancer	2.44e-06	2.63e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—GSTM1—kidney cancer	2.43e-06	2.62e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—POMC—kidney cancer	2.43e-06	2.62e-05	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—PIK3CA—kidney cancer	2.42e-06	2.61e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—HIF1A—kidney cancer	2.42e-06	2.61e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TSC2—kidney cancer	2.42e-06	2.61e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—RAF1—kidney cancer	2.39e-06	2.58e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—SCARB1—kidney cancer	2.38e-06	2.57e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CDKN1B—kidney cancer	2.37e-06	2.56e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—ERBB2—kidney cancer	2.37e-06	2.55e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS1—kidney cancer	2.36e-06	2.55e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—POMC—kidney cancer	2.35e-06	2.53e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—POMC—kidney cancer	2.35e-06	2.53e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PTEN—kidney cancer	2.35e-06	2.53e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—HIF1A—kidney cancer	2.34e-06	2.53e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—HIF1A—kidney cancer	2.34e-06	2.53e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TSC2—kidney cancer	2.34e-06	2.52e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TSC2—kidney cancer	2.34e-06	2.52e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MTOR—kidney cancer	2.33e-06	2.52e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—CD4—kidney cancer	2.33e-06	2.51e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.33e-06	2.51e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.33e-06	2.51e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—IL2—kidney cancer	2.32e-06	2.51e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KDR—kidney cancer	2.32e-06	2.5e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PSMD7—kidney cancer	2.31e-06	2.5e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PTGS2—kidney cancer	2.31e-06	2.5e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—RAF1—kidney cancer	2.31e-06	2.5e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—RAF1—kidney cancer	2.31e-06	2.5e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.31e-06	2.49e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—POMC—kidney cancer	2.3e-06	2.49e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CDKN1B—kidney cancer	2.3e-06	2.48e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CDKN1B—kidney cancer	2.3e-06	2.48e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.29e-06	2.48e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—ERBB2—kidney cancer	2.29e-06	2.47e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—ERBB2—kidney cancer	2.29e-06	2.47e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—GSTP1—kidney cancer	2.26e-06	2.44e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—JUN—kidney cancer	2.26e-06	2.44e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MTOR—kidney cancer	2.26e-06	2.44e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MTOR—kidney cancer	2.26e-06	2.44e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CD4—kidney cancer	2.25e-06	2.43e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CD4—kidney cancer	2.25e-06	2.43e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—IL2—kidney cancer	2.25e-06	2.42e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—IL2—kidney cancer	2.25e-06	2.42e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CTNNB1—kidney cancer	2.24e-06	2.42e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KDR—kidney cancer	2.24e-06	2.42e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KDR—kidney cancer	2.24e-06	2.42e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PTGS2—kidney cancer	2.24e-06	2.41e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PTGS2—kidney cancer	2.24e-06	2.41e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—BCHE—kidney cancer	2.19e-06	2.37e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—CDKN1B—kidney cancer	2.19e-06	2.36e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—JUN—kidney cancer	2.19e-06	2.36e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—JUN—kidney cancer	2.19e-06	2.36e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—PTEN—kidney cancer	2.18e-06	2.36e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CTNNB1—kidney cancer	2.17e-06	2.34e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CTNNB1—kidney cancer	2.17e-06	2.34e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.17e-06	2.34e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PTEN—kidney cancer	2.15e-06	2.32e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ABCB1—kidney cancer	2.14e-06	2.31e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—APC—kidney cancer	2.13e-06	2.3e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KIT—kidney cancer	2.13e-06	2.3e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CDKN1B—kidney cancer	2.12e-06	2.29e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CDKN1B—kidney cancer	2.12e-06	2.29e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PTEN—kidney cancer	2.11e-06	2.28e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PTEN—kidney cancer	2.11e-06	2.28e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—POMC—kidney cancer	2.11e-06	2.28e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.09e-06	2.26e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—GSTM1—kidney cancer	2.08e-06	2.24e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—CTNNB1—kidney cancer	2.07e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KIT—kidney cancer	2.06e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—APC—kidney cancer	2.06e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—APC—kidney cancer	2.06e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KIT—kidney cancer	2.06e-06	2.23e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—MAPK3—kidney cancer	2.04e-06	2.2e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—POMC—kidney cancer	2.03e-06	2.19e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PTEN—kidney cancer	2.02e-06	2.18e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—BRAF—kidney cancer	2.01e-06	2.16e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—CTNNB1—kidney cancer	2e-06	2.16e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—CTNNB1—kidney cancer	2e-06	2.16e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTGS2—kidney cancer	1.99e-06	2.15e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—MAPK3—kidney cancer	1.98e-06	2.13e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—MAPK3—kidney cancer	1.98e-06	2.13e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—CYP1A1—kidney cancer	1.97e-06	2.13e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—POMC—kidney cancer	1.96e-06	2.12e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—POMC—kidney cancer	1.96e-06	2.12e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PTEN—kidney cancer	1.95e-06	2.11e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PTEN—kidney cancer	1.95e-06	2.11e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTGS2—kidney cancer	1.95e-06	2.1e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTGS2—kidney cancer	1.95e-06	2.1e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—MAPK1—kidney cancer	1.94e-06	2.1e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—BRAF—kidney cancer	1.94e-06	2.09e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—BRAF—kidney cancer	1.94e-06	2.09e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTGS2—kidney cancer	1.94e-06	2.09e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.89e-06	2.04e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—MAPK1—kidney cancer	1.88e-06	2.03e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—MAPK1—kidney cancer	1.88e-06	2.03e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTGS2—kidney cancer	1.87e-06	2.02e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTGS2—kidney cancer	1.87e-06	2.02e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—MAPK3—kidney cancer	1.87e-06	2.01e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—POMC—kidney cancer	1.84e-06	1.99e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTGS2—kidney cancer	1.84e-06	1.98e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—KRAS—kidney cancer	1.84e-06	1.98e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MAPK3—kidney cancer	1.81e-06	1.95e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MAPK3—kidney cancer	1.81e-06	1.95e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—MAPK1—kidney cancer	1.78e-06	1.92e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—KRAS—kidney cancer	1.78e-06	1.92e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—KRAS—kidney cancer	1.78e-06	1.92e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTP1—kidney cancer	1.75e-06	1.88e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTEN—kidney cancer	1.74e-06	1.87e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—POMC—kidney cancer	1.73e-06	1.87e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MAPK3—kidney cancer	1.72e-06	1.86e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—POMC—kidney cancer	1.72e-06	1.86e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MAPK1—kidney cancer	1.72e-06	1.85e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MAPK1—kidney cancer	1.72e-06	1.85e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTEN—kidney cancer	1.7e-06	1.83e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTEN—kidney cancer	1.7e-06	1.83e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTEN—kidney cancer	1.69e-06	1.82e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PIK3CA—kidney cancer	1.69e-06	1.82e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTGS2—kidney cancer	1.69e-06	1.82e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KRAS—kidney cancer	1.68e-06	1.81e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MYC—kidney cancer	1.68e-06	1.81e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—RAF1—kidney cancer	1.67e-06	1.81e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MAPK3—kidney cancer	1.67e-06	1.8e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MAPK3—kidney cancer	1.67e-06	1.8e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—RELA—kidney cancer	1.67e-06	1.8e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—ERBB2—kidney cancer	1.66e-06	1.79e-05	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PIK3CA—kidney cancer	1.66e-06	1.79e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ABCB1—kidney cancer	1.65e-06	1.78e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—MAPK1—kidney cancer	1.64e-06	1.77e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MTOR—kidney cancer	1.63e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTEN—kidney cancer	1.63e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTEN—kidney cancer	1.63e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PIK3CA—kidney cancer	1.63e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PIK3CA—kidney cancer	1.63e-06	1.76e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KRAS—kidney cancer	1.62e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KRAS—kidney cancer	1.62e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MYC—kidney cancer	1.62e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MYC—kidney cancer	1.62e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—RAF1—kidney cancer	1.62e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—RAF1—kidney cancer	1.62e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.62e-06	1.75e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—RELA—kidney cancer	1.61e-06	1.74e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—RELA—kidney cancer	1.61e-06	1.74e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—GSTM1—kidney cancer	1.6e-06	1.73e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTEN—kidney cancer	1.6e-06	1.73e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—ERBB2—kidney cancer	1.6e-06	1.73e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—ERBB2—kidney cancer	1.6e-06	1.73e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—MAPK1—kidney cancer	1.59e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—MAPK1—kidney cancer	1.59e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MTOR—kidney cancer	1.58e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MTOR—kidney cancer	1.58e-06	1.71e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—KRAS—kidney cancer	1.55e-06	1.67e-05	CbGpPWpGaD
Nifedipine—CALM3—Immune System—PIK3CA—kidney cancer	1.54e-06	1.66e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CDKN1B—kidney cancer	1.53e-06	1.66e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.52e-06	1.64e-05	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PIK3CA—kidney cancer	1.52e-06	1.64e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IL2—kidney cancer	1.5e-06	1.62e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—KRAS—kidney cancer	1.5e-06	1.62e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—KRAS—kidney cancer	1.5e-06	1.62e-05	CbGpPWpGaD
Nifedipine—CALM2—Immune System—PIK3CA—kidney cancer	1.49e-06	1.61e-05	CbGpPWpGaD
Nifedipine—CALM1—Immune System—PIK3CA—kidney cancer	1.49e-06	1.61e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CDKN1B—kidney cancer	1.48e-06	1.6e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CDKN1B—kidney cancer	1.48e-06	1.6e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTEN—kidney cancer	1.47e-06	1.59e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—POMC—kidney cancer	1.47e-06	1.59e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTGS2—kidney cancer	1.47e-06	1.58e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CCND1—kidney cancer	1.46e-06	1.58e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—JUN—kidney cancer	1.46e-06	1.58e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IL2—kidney cancer	1.45e-06	1.57e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IL2—kidney cancer	1.45e-06	1.57e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CTNNB1—kidney cancer	1.45e-06	1.56e-05	CbGpPWpGaD
Nifedipine—CALM3—Disease—PIK3CA—kidney cancer	1.42e-06	1.54e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CCND1—kidney cancer	1.42e-06	1.53e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CCND1—kidney cancer	1.42e-06	1.53e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—JUN—kidney cancer	1.41e-06	1.52e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—JUN—kidney cancer	1.41e-06	1.52e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PTEN—kidney cancer	1.41e-06	1.52e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CTNNB1—kidney cancer	1.4e-06	1.51e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CTNNB1—kidney cancer	1.4e-06	1.51e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTGS2—kidney cancer	1.38e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CALM1—Disease—PIK3CA—kidney cancer	1.38e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CALM2—Disease—PIK3CA—kidney cancer	1.38e-06	1.49e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTGS2—kidney cancer	1.37e-06	1.48e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PTEN—kidney cancer	1.37e-06	1.47e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PTEN—kidney cancer	1.37e-06	1.47e-05	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTEN—kidney cancer	1.28e-06	1.38e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—kidney cancer	1.28e-06	1.38e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—kidney cancer	1.23e-06	1.33e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—kidney cancer	1.23e-06	1.33e-05	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.22e-06	1.32e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAPK3—kidney cancer	1.21e-06	1.3e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTEN—kidney cancer	1.21e-06	1.3e-05	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PIK3CA—kidney cancer	1.2e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.2e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTEN—kidney cancer	1.2e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PIK3CA—kidney cancer	1.19e-06	1.29e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MYC—kidney cancer	1.17e-06	1.27e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS2—kidney cancer	1.17e-06	1.26e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAPK3—kidney cancer	1.17e-06	1.26e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAPK3—kidney cancer	1.17e-06	1.26e-05	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PIK3CA—kidney cancer	1.15e-06	1.24e-05	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PIK3CA—kidney cancer	1.15e-06	1.24e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MAPK1—kidney cancer	1.15e-06	1.24e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MYC—kidney cancer	1.14e-06	1.23e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MYC—kidney cancer	1.14e-06	1.23e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—POMC—kidney cancer	1.13e-06	1.22e-05	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PIK3CA—kidney cancer	1.13e-06	1.22e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MAPK1—kidney cancer	1.11e-06	1.2e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MAPK1—kidney cancer	1.11e-06	1.2e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KRAS—kidney cancer	1.08e-06	1.17e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KRAS—kidney cancer	1.05e-06	1.13e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KRAS—kidney cancer	1.05e-06	1.13e-05	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.04e-06	1.12e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTEN—kidney cancer	1.02e-06	1.1e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PIK3CA—kidney cancer	9.97e-07	1.08e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—kidney cancer	9.64e-07	1.04e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PIK3CA—kidney cancer	9.64e-07	1.04e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PIK3CA—kidney cancer	9.64e-07	1.04e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—kidney cancer	9.33e-07	1.01e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—kidney cancer	9.33e-07	1.01e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS2—kidney cancer	9.04e-07	9.76e-06	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PIK3CA—kidney cancer	9.03e-07	9.74e-06	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PIK3CA—kidney cancer	8.51e-07	9.18e-06	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PIK3CA—kidney cancer	8.44e-07	9.1e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTEN—kidney cancer	7.89e-07	8.51e-06	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PIK3CA—kidney cancer	7.21e-07	7.78e-06	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PIK3CA—kidney cancer	5.56e-07	6e-06	CbGpPWpGaD
